Since the late ’60s, menopausal hormone therapy has been touted as not just a tool for alleviating menopausal discomfort but as a way to preemptively protect women against cardiovascular disease, cancer and stroke.

One-third of diabetic patients prescribed metformin—the mostly commonly recommended diabetes drug—aren’t taking the medication due to side effects ranging from diarrhea to depression, researchers in the United Kingdom have found.

Life expectancy is declining for American women, according to a recent CBS report—and it’s mostly due to preventable disease.

Erectile dysfunction could be an early warning sign of subclinical cardiovascular disease (CVD), especially in young men whose CVD risks aren’t steadily monitored, researchers reported in Vascular Medicine this December.

A blood test for high-sensitivity troponin T (hsTnT) used in emergency departments successfully ruled out myocardial infarction (MI) and helped identify patients at low 30-day risk for adverse cardiac events, researchers reported in JAMA Cardiology.

A Swedish study of nearly 5,000 patients has proven the efficacy of death receptors as markers for type 2 diabetes and cardiovascular disease, according to research published in EBioMedicine.

Results from a recently published study suggest blood pressure begins to decline up to 18 years before death, with the sharpest dip occurring in the final two years.

New technology developed at New York’s Binghamton University could change the way clinicians detect heart disease with MRI scans, research published in the journal Colloid and Surfaces B: Biointerfaces suggests.